Objective To determine the rate of placental apoptosis and adverse perinatal outcome in patients with late-onset pre-eclampsia (PE) 
INTRODUCTION
Pre-eclampsia (PE) is a multisystemic disorder of pregnancy defined as hypertension and proteinuria 1 . It is one of the major causes of maternal and fetal morbidity and mortality worldwide 2, 3 . From a pathophysiological perspective, PE is characterized by increased peripheral vascular resistance and endothelial dysfunction [4] [5] [6] . During the preclinical stage of the disease, an important process, characterized by apoptosis of the syncytiotrophoblast, occurs [7] [8] [9] . The apoptotic process leads to the release of syncytiotrophoblast microparticles (STM) into the bloodstream, triggering an inflammatory process, endothelial damage and, finally, endothelial dysfunction [10] [11] [12] .
Currently, PE is classified into early-and late-onset forms, depending on the gestational age at diagnosis and/or delivery 13, 14 . Late-onset PE accounts for 80-90% of PE worldwide 15 and is characterized by a better prognosis, but a more unpredictable outcome, than is the early-onset form 16 . However, recent studies have shown that abnormal uterine artery (UtA) Doppler at diagnosis of late PE can be used to predict more severe adverse perinatal outcomes, such as lower birth weight, lower gestational age at delivery and increased rate of admission to the neonatal intensive care unit (NICU) 17, 18 . Recent evidence has demonstrated that abnormal UtA Doppler at diagnosis is also associated with increased rate of placental damage in both early and late forms 19 . However, placental apoptotic status has not been evaluated for late PE.
The aim of this study was to determine the rate of placental apoptosis and adverse perinatal outcome in patients with late PE and abnormal UtA Doppler at diagnosis.
METHODS

Study design and participants
This was a prospective cohort study of women with singleton pregnancy diagnosed with late PE, performed between August 2011 and January 2014 at the Maternal-Fetal Medicine Unit of Hospital Carlos Van Buren. PE was defined as new-onset hypertension and proteinuria according to diagnostic criteria of the International Society for the Study of Hypertension of Pregnancy 20 . Patients diagnosed with PE at or after 34 weeks of gestation were categorized as late PE, as described previously 15 . Pregnancies with PE diagnosed before 34 weeks, twin gestations or fetuses with major birth defects, chromosomal abnormalities or suspected genetic syndromes were excluded.
At the time of admission, maternal demographic and clinical data were collected. Clinical characteristics and medical history of patients included in the analysis consisted of maternal age, height, weight at admission, body mass index (BMI), parity, obstetric background (history of PE, preterm delivery or gestational diabetes), chronic diseases (chronic hypertension, pregestational diabetes or autoimmune disease) and gestational age based on first-trimester crown-rump length (CRL). Perinatal characteristics recorded were gestational age at birth, birth weight and birth-weight percentile. Birth-weight percentile was calculated based on national neonatal curves 21 . All patients at the time of diagnosis underwent obstetric ultrasound with assessment of fetal biometry, amniotic fluid and Doppler studies. UtA Doppler assessment was performed transabdominally. With the use of color Doppler, the crossover between the external iliac artery and the UtA was identified. Measurement was performed 1 cm distal to the junction of the two arteries, as described previously 22 . The average pulsatility index (PI) of the right and left UtAs was calculated for the analysis. Abnormal UtA Doppler was defined as average UtA-PI above the 95 th percentile for gestational age according to reference curves described by Gomez et al. 22 . For umbilical artery, ductus venosus and middle cerebral artery assessment, reference curves described by Parra-Cordero et al. 23 were used. All measurements were performed by two trained operators (C.C. and M.R.) using Sonoace X6 (Samsung Medison Co. Ltd., Seoul, South Korea) and Voluson S6 (GE Medical Systems, Zipf, Austria) ultrasound machines with a high-frequency transabdominal transducer.
Patients were hospitalized and were monitored serially for blood pressure, biochemical markers of severe PE and fetal wellbeing. Pregnancies were delivered at 38 weeks in the case of mild PE. In the case of signs of severe PE, termination of the pregnancy was recommended and the route of delivery was determined according to the obstetric conditions. Severe PE was defined as the presence of: hypertensive crisis refractory to medical treatment, eclampsia, persistent neurological symptoms, abnormal liver tests, hemolysis, thrombocytopenia, renal dysfunction, massive proteinuria (> 5 g/24 h), placental abruption or fetal growth restriction (defined as an estimated fetal weight below the 10 th percentile with abnormal fetal Doppler or biophysical profile).
During clinical follow-up, adverse maternal outcomes considered for analysis were: hypertensive crisis; refractory hypertensive crisis after the use of two antihypertensive drugs; eclampsia; intensive care unit (ICU) admission; requirement for transfusion of blood products; maternal death; emergency Cesarean section; and placental abruption. Adverse perinatal outcomes considered for analysis were perinatal death, birth weight below the 10 th percentile, admission to NICU or indicated preterm delivery. Composite perinatal outcome was defined as one or more of: preterm birth before 37 weeks; emergency delivery for maternal or fetal indication; low birth weight (below the 10 th percentile); or admission to NICU. The Ethics Committee of the University of Valparaiso approved the study and patients provided informed consent (Ethics Committee N • 17/2012).
Placental morphology study
As there are no studies regarding apoptosis in patients with late PE and abnormal UtA Doppler, a histopathological pilot study was performed using placental samples from 25 women for whom samples were available: six from normotensive controls with delivery after 34 weeks; nine from women with late PE with normal UtA Doppler; and 10 from women with late PE with abnormal UtA Doppler.
Because of the association of intermittent hypoxiareperfusion of the placenta during labor, only samples derived from normal labor with normal fetal wellbeing or from Cesarean section without labor were included. Patients with late PE were divided into those with and those without increased UtA resistance according to UtA-PI percentile (> or ≤ 95 th percentile). Placental tissue of patients with late PE and comorbidities, such as diabetes or chronic hypertension, were excluded from the histological study.
Placentae were fixed in 10% formalin immediately after delivery for a minimum time period of 24 h. Then, samples were weighed after removal of the membranes (chorion and amnion) and umbilical cord. For each placenta, tissue samples from central cotyledons close to the insertion of the umbilical cord and peripheral cotyledons close to ovular membranes were collected.
Samples from the umbilical cord and a roller of the membranes were also obtained. The obtained samples were dehydrated in an increasing ethanol concentration series and mounted in paraffin. Next, histological sections 5 μm in thickness were obtained. Slides were coded and anonymized.
On comparative analysis, placental weight with its percentile adjusted for gestational age was recorded. On this basis, placentae with weight < 10 th percentile were classified as hypotrophic 24 . Histological findings were categorized according to the classification proposed by the International Federation of Placenta 25 for fetal vascular alterations, maternal vascular alterations and inflammatory alterations. In addition, a morphological evaluation of the number of capillaries per villus was performed to create the villus capillary index (VCI), which was calculated using the following formula: total number of capillaries/total number of villi.
For each placenta, 10 random microscopic fields were evaluated from both central and peripheral samples. This process was performed using a 100× objective and calculated using the mean VCI for each placenta. Each morphological evaluation was performed by the same observer who is a pathologist dedicated to the study of placentae (C.L.) and was blinded to the clinical history and results.
Determination of placental apoptosis
Placental apoptosis was examined in tissue samples of central and peripheral cotyledons. To determine the rate of apoptosis, an immunohistochemical analysis using rabbit anti-human active caspase 3 (Abcam ab13847; Abcam, Cambridge, UK) was performed. Immunostaining of the samples was performed according to the manufacturer's instructions after deparaffinization and rehydration. Antigen retrieval was then performed by immersing the slide in sodium citrate (10 mM, pH 6.0) for 15 min at 95
• C, as described previously 26 . Endogenous peroxidase and non-specific sites were blocked followed by incubation for 16 h at 4
• C with the primary antibody, rabbit anti-(human active caspase 3), at a 1:500 dilution in phosphate-buffered saline (PBS)/Tween 20. Next, secondary antibody, goat anti-rabbit IgG (Invitrogen) conjugated to horseradish peroxidase (HRP), was added at a 1:500 dilution in PBS and incubated for 1.5 min at 25
• C. Antigen-antibody binding was revealed using the NovaRED kit (Vector Laboratories, Burlinghame, CA, USA) after which the slides were counterstained with hematoxylin to reveal the cell nuclei. Embryonic and fetal murine tissue samples served as a positive control and slides with no primary antibody incubation served as a negative control.
For each placenta, 20 random images were obtained using an Olympus CX31 microscope under 100× magnification. Of these, 10 corresponded to the central sample and 10 corresponded to the peripheral sample. Each image was obtained using a digital Olympus DP71 camera and DP controller software (Olympus, Tokyo, Japan). The apoptotic index (AI) was determined using Image J v1.47 software (NIH, Bethesda, MD, USA). To achieve this, active caspase 3-labeled and caspase 3-non-labeled trophoblastic cells were quantified if they were present in the placental villus captured in a transverse section and had a complete perimeter. AI was calculated using the following formula: (number of apoptotic trophoblastic cells/total number of trophoblastic cells) × 100. A single observer, who was blinded to the clinical history and clinical results, performed all quantifications.
Statistical analysis
Distribution of continuous variables was evaluated using the Shapiro-Wilk test. Parametric and non-parametric data were expressed as mean ± SD and median (interquartile range), respectively. Categorical variables were expressed as n (%). Pre-and postnatal adverse clinical outcomes of patients with late PE were compared according to the presence or absence of abnormal UtA Doppler.
For continuous variables, Student's t-test or Mann-Whitney U-test was performed for parametric and non-parametric data, respectively. For categorical variables, the chi-square test or Fisher's exact test was used. Odds ratios (ORs) were calculated with 95% CI using univariate logistic regression analysis. For analysis of the histological assessment of placentae, a normotensive control group was included. For comparison of placental weights, and capillary/villus and apoptotic indices, the Jonckheere-Terpstra test for non-parametric linear trend data was used with post-hoc intergroup analysis using the Bonferroni test. Rate of apoptosis and placental hypotrophy were analyzed using Fisher's exact test. Data were analyzed using STATA, v14.0 (Stata Corp., College Station, TX, USA). For all tests, a value of P < 0.05 was considered to be statistically significant.
RESULTS
Eighty-six patients fulfilled the inclusion criteria and provided informed consent to participate in the study. Maternal characteristics are described in Table 1 . In 33 (38.4%) patients, UtA Doppler was above the 95 th percentile. There were no differences in maternal age, parity or BMI between patients with abnormal and normal UtA Doppler. The presence of chronic disease was also similar between the groups. Gestational age at diagnosis was significantly lower in patients with abnormal UtA Data are given as mean ± SD, median (interquartile range) or n (%). Doppler than in those with normal UtA Doppler (35.8 weeks vs 36.9 weeks, respectively; P = 0.002).
Thirty-four (39.5%) patients required emergency delivery because of severe PE. In 19 (55.9%) of these cases, delivery was for maternal indication (refractory hypertensive crisis, eclampsia, neurological symptoms, placental abruption, acute pulmonary edema or massive proteinuria). The remaining 15 cases were delivered for fetal indication (fetal growth restriction with abnormal Doppler or non-reassuring fetal wellbeing). Thirteen newborns were admitted to the NICU. Table 2 shows maternal and perinatal outcomes according to UtA Doppler at diagnosis of late PE. Logistic regression analysis demonstrated a seven-fold increased risk of severe PE in patients with abnormal UtA Doppler (OR = 7.5; 95% CI, 2.76-20.46; P < 0.001). Abnormal UtA Doppler was also associated with a significantly increased risk of late-preterm delivery (OR = 13.7; 95% CI, 4.53-41.46; P < 0.001) and indicated preterm delivery (OR = 11.5; 95% CI, 3.66-36.31; P < 0.001). However, there was no increased risk of Cesarean section in patients with abnormal UtA Doppler (OR = 1.3; 95% CI, 0.47-3.75; P = 0.6).
Perinatal outcome according to UtA Doppler
Regarding perinatal outcome, UtA Doppler > 95 th percentile was associated with an increased risk of small-for-gestational age (OR = 12.3; 95% CI, 3.17-47.57; P < 0.001), that represents a rate of 42% vs 6% in the normal UtA Doppler group (Table 2) . NICU admission was also significantly higher in the abnormal Doppler group (OR = 12.8; 95% CI, 2.61-62.36; P = 0.002). Figure 1 shows the significant negative correlation of UtA Doppler with birth weight (r = -0.34; P = 0.0013). Composite adverse perinatal outcome was observed in 29 (33.7%) patients. There was a 13-fold increased risk in patients with abnormal UtA Doppler at diagnosis (OR = 13.1; 95% CI, 4.48-38.52; P < 0.001). During the postnatal period, hypertensive crisis was nearly five times more common in patients with a UtA Doppler > 95 th percentile (OR = 4.5; 1.07-18.81; P = 0.04).
Placental macroscopic assessment
Demographic and clinical characteristics of patients in whom placental samples were available are described in Table 3 . There were no significant differences in Data are given as mean ± SD, n (%) or median (interquartile range). Continuous variables were compared using ANOVA with post-hoc analysis using the Scheffé test, or the Kruskal-Wallis test with post-hoc analysis using the Mann-Whitney U-test, for parametric and non-parametric data, respectively. Categorical variables were compared with the chi-square test or Fisher's exact test. *P < 0.05 vs late PE with normal UtA Doppler. †Mann-Whitney U-test excluding controls for analysis. GA, gestational age; HT, hypertension; NA, not applicable. background maternal or perinatal characteristics between the groups.
Placental weight decreased linearly according to the severity of PE (610 ± 84.6 g, 500 ± 115.4 g and 377 ± 149.9 g for controls, late PE with normal UtA Doppler and late PE with abnormal UtA Doppler, respectively (P < 0.001)). In 80% of patients with abnormal UtA Doppler, placental weight was below the 10 th percentile (hypotrophic), compared with 44.4% in patients with late PE and normal UtA Doppler, and 16.7% in normotensive controls (P = 0.007).
Vascular and apoptotic assessment of placental tissue
Comparison between controls and women with late PE with normal or abnormal UtA Doppler demonstrated non-significant differences in vascular maldevelopment, obstruction and loss of integrity for the maternal vascular side of the placenta (Table 4) , with similarly non-significant differences for VCI (Figure 2) . However, maldevelopment of fetal vascularity presented a significantly linear increase according to the severity of the disease (Table 4) .
On determination of caspase expression in placental samples (Figure 3) , cotyledons closer to the umbilical cord presented a trend of increased apoptosis according to severity of the disease. However, this finding was not significant. A similar finding was obtained in peripheral cotyledons. However, when apoptosis was analyzed as a mean of both locations, a significant trend was observed (Table 4 and Figure 4) .
DISCUSSION
Approximately 80% of all PE is late onset. This form is commonly associated with maternal conditions preconception, such as obesity and diabetes mellitus [14] [15] [16] . However, association with adverse perinatal outcome or placental insufficiency manifestations (i.e. severe PE or intrauterine growth restriction) is rare.
Recent studies have demonstrated that the clinical behavior of late PE can be divided into two categories, according to the degree of alteration of UtA Doppler at diagnosis 17, 18, 27 . In our study, placental morphological assessment did not show a significant difference in the rate of altered maternal vessels between patients with PE (independent of UtA Doppler) and normotensive controls. Moreover, VCI did not demonstrate any difference. However, an increased rate of fetal vascular abnormalities in the placenta could be one factor involved in the higher rate of small-for-gestational age in patients with abnormal UtA Doppler.
The similarities between placental samples of patients with late PE and controls are consistent with previously published placental histological studies. In contrast, the increased rate of placental hypotrophy and altered vasculogenesis in both the maternal and fetal side of the placenta has been demonstrated primarily in the early form of this disease [28] [29] [30] [31] . Our study demonstrated a significant linear correlation between the severity of the disease and placental apoptosis. This is consistent with the concept of placental hypoxia as a stimulus for villous apoptosis 32 . As demonstrated previously by several studies, UtA Doppler is a non-invasive assessment of the placentation process 33, 34 . Thus, increased rate of apoptosis in placenta affected by PE and abnormal UtA Doppler was an expected finding.
Regarding obstetric outcome, in patients with late PE, abnormal UtA Doppler was associated with increased rate of preterm delivery, SGA and admission to NICU. Our results are consistent with those of a study by Crispi et al., in which patients with late PE and abnormal UtA Doppler had lower gestational age at birth and birth weight compared with those with late PE but normal UtA Doppler 27 . Moreover, Ghi et al. found a 51% incidence of abnormal UtA Doppler at diagnosis of PE 17 . In these patients, abnormal UtA Doppler was associated with more severe neonatal outcome. According to these two studies, late PE could be classified clinically and pathophysiologically into two groups. Placental apoptosis is a mediator of trophoblast damage and systemic endothelial dysfunction is caused by STM produced during this process. Several studies have demonstrated that placental apoptosis is increased in patients with early-onset PE, but not in those with the late-onset form of the disease.
In late PE, the most likely cause is a systemic inflammatory status and not of placental origin 35 . However, in the present study, a subgroup of late PE appears to have placental origin, based on increased trophoblastic apoptosis identified and altered placentation process according to UtA Doppler status. Moreover, adverse clinical outcome was similar to that in early PE, although was not as severe.
The primary strengths of this study are that it is the first to assess the presence of placental apoptosis in patients with late PE and to identify the correlation with abnormal UtA Doppler. Moreover, the findings of this study improve knowledge of the importance of UtA Doppler in clinical management and prognosis of late PE.
However, several weaknesses should be acknowledged. First, the small sample size for placental analysis may be associated with bias in the interpretation of the results. Second, we did not obtain a maternal blood sample at diagnosis for determination of biochemical markers of apoptosis and angiogenesis/anti-angiogenesis; several studies have correlated these markers with UtA Doppler status 36, 37 . However, it would be of interest to determine if there is also an association of peripheral markers with placental apoptosis.
Based on the current findings, we propose to focus analysis of the fetal part of the placenta on central cotyledons, and proximal and distal cord samples in future studies. Moreover, we propose to determine the angiogenic status in maternal blood at diagnosis and in cord blood at delivery and to correlate placental findings with the assessment of umbilical artery Doppler as a non-invasive evaluation of the fetal side of the placenta.
In conclusion, assessment of UtA Doppler in late PE appears to be a useful technique for identifying PE with placental origin, as it has a strong association with placental apoptosis and adverse perinatal outcome. Therefore, the use of UtA Doppler for classification, management and follow-up of late PE appears to be promising and requires further study. As part of the clinical management of patients with PE, current national guidelines do not include assessment of UtA Doppler for severity classification of PE. However, we believe strongly that, with further research, in the future there could be sufficient evidence to change the way in which PE is managed. We are therefore planning to perform a multicenter cohort study in three university hospitals to determine the real value of UtA Doppler as a severity marker of the disease.
